Animal anatomy

Cerevel Therapeutics to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021

Retrieved on: 
Thursday, July 22, 2021

CAMBRIDGE, Mass., July 22, 2021 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain totreatneurosciencediseases, today announced it will report second quarter 2021 financial results and provide a pipeline update on Wednesday, August 11, 2021, before the U.S. financial markets open.

Key Points: 
  • CAMBRIDGE, Mass., July 22, 2021 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain totreatneurosciencediseases, today announced it will report second quarter 2021 financial results and provide a pipeline update on Wednesday, August 11, 2021, before the U.S. financial markets open.
  • Management will host a conference call to discuss second quarter 2021 financial results and recent business and pipeline updates on Wednesday, August 11, 2021 at 8:00 a.m. EDT.
  • Cerevel Therapeutics is dedicated to unraveling the mysteries of the brain to treat neuroscience diseases.
  • Forward-looking statements in this press release include, but are not limited to, statements about the timing of reporting of our second quarter 2021 financial results and the potential attributes and benefits of our product candidates.

Researchers Image an Entire Mouse Brain for the First Time

Retrieved on: 
Thursday, July 8, 2021
Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20210708005904/en/
    A team of scientists with Argonne and UChicago visualized an entire mouse brain from synapses on up.
  • Above, a visualization of whole brain interconnectivity, with colors depicting directionality.
  • Using X-ray tomography, researchers were able to image the entire mouse brain roughly one cubic centimeter at the resolution of a micron.
  • But also, the mouse is the workhorse of neuroscience; theyre very useful for analyzing different experimental conditions in the brain.

Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders

Retrieved on: 
Wednesday, May 12, 2021

The Company offers a portfolio of high-quality, science-based non-prescription skincare products and early to commercial stage prescription products.

Key Points: 
  • The Company offers a portfolio of high-quality, science-based non-prescription skincare products and early to commercial stage prescription products.
  • The portfolio is designed to address preventive care to combating the first signs of aging, as well as all primary aesthetic skin concerns.
  • In Canada, our national sales force calls on aesthetic practitioners and medical aesthetic clinics and medispas using a business to business to consumer model.
  • Pliaglis is a topical local anesthetic cream that provides safe and effective local dermal analgesia on intact skin prior to superficial dermatological procedures.

VoxNeuro Empowers Americans to Take Control of Their Brain Health

Retrieved on: 
Tuesday, May 11, 2021

\xe2\x80\x9cClinicians will have more certainty, with more objective information about how a patient\xe2\x80\x99s brain is functioning.

Key Points: 
  • \xe2\x80\x9cClinicians will have more certainty, with more objective information about how a patient\xe2\x80\x99s brain is functioning.
  • \xe2\x80\x9cSimply put, this technology will empower Americans to take control of their brain health,\xe2\x80\x9d Connolly added.\nVoxNeuro has worked closely with the Principle of Western New York Medical Imaging Group over the past year on market entrance strategy.
  • "\nVoxNeuro is positioned to globally change the way brain health is managed and treated.
  • To learn more, follow VoxNeuro on LinkedIn , Twitter , Instagram , Facebook and YouTube .\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210511005877/en/\n'

Butterbean Organics Voted the Best Natural Mineral Sunscreen Third Year In a Row By Kitchen Stewardship

Retrieved on: 
Sunday, May 2, 2021

The company\'s ethos includes the promise of sustainability in packaging and certified organic ingredient sourcing abilities, empowering small local businesses, and practicing Fair Trade.

Key Points: 
  • The company\'s ethos includes the promise of sustainability in packaging and certified organic ingredient sourcing abilities, empowering small local businesses, and practicing Fair Trade.
  • "Our natural mineral sunscreens aim at creating a barrier on your child\'s delicate skin that will prevent the sun\'s harmful impact to penetrate the epidermis and permanently damage its tissue.
  • Butterbean Organics is grateful for the honorable recognition and strives to continue making a positive impact on the health of our children and the planet.
  • It is in our hands to choose the top quality products for the fragile skin of our children.\n'

PureTech Announces Nature Publication Supporting Modulation of Meningeal Lymphatics to Target Alzheimer’s Disease Pathologies

Retrieved on: 
Wednesday, April 28, 2021

View the full release here: https://www.businesswire.com/news/home/20210428005790/en/\nPureTech announced the publication of new research in Nature, which demonstrates that modulation of meningeal lymphatics may help to address Alzheimer\xe2\x80\x99s disease pathologies.

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20210428005790/en/\nPureTech announced the publication of new research in Nature, which demonstrates that modulation of meningeal lymphatics may help to address Alzheimer\xe2\x80\x99s disease pathologies.
  • PureTech is advancing this work via its wholly-owned meningeal lymphatics research program.
  • (Graphic: Business Wire)\nPureTech holds an exclusive license to the underlying intellectual property and is advancing this work via its wholly-owned meningeal lymphatics research program.
  • The new paper builds on foundational research published in Nature in 2018, in which Dr. Kipnis\xe2\x80\x99s lab showed that disrupting meningeal lymphatic drainage promoted A\xce\xb2 accumulation in preclinical models of Alzheimer\xe2\x80\x99s disease.

Global $362 Million Wireless Brain Sensors Market Analysis and Forecast to 2030: Examine Case Studies to Assess the Delivery Models and Strategies Adopted by Some of the Highly Funded Players

Retrieved on: 
Monday, March 22, 2021

The report constitutes an in-depth analysis of the global wireless brain sensors market, including a thorough analysis of the applications.

Key Points: 
  • The report constitutes an in-depth analysis of the global wireless brain sensors market, including a thorough analysis of the applications.
  • This section of the report encompasses the following:
    Key Questions Answered in this Report:
    How has COVID-19 impacted the global wireless brain sensors market?
  • Which are the leading players that currently hold significant dominance in the global wireless brain sensors market?
  • What is the current market potential of wireless brain sensors, and what factors decide the growth potential of wireless brain sensors for the forecast period?

DGAP-News: B.R.A.I.N. Biotechnology Research And Information Network AG: Resolutions of the Annual General Meeting for the Fiscal Year 2019/2020 of BRAIN AG

Retrieved on: 
Wednesday, March 10, 2021

Biotechnology Research And Information Network AG: Resolutions of the Annual General Meeting for the Fiscal Year 2019/2020 of BRAIN AG

Key Points: 
  • Biotechnology Research And Information Network AG: Resolutions of the Annual General Meeting for the Fiscal Year 2019/2020 of BRAIN AG
    The issuer is solely responsible for the content of this announcement.
  • Biotechnology Research and Information Network AG (BRAIN AG), the discharge of the Executive Board and Supervisory Board was approved by a large majority.
  • All of the Annual General Meeting resolutions were passed by the shareholders, including the application for conditional and authorized capital as well as the change of the company name to BRAIN Biotech AG.
  • Numerous factors exist that could influence the future performance by, and future developments at, BRAIN AG and the BRAIN Group.

PureTech Announces Publication of Glyph™ Platform Preclinical Proof-of-Concept Study in Journal of Controlled Release

Retrieved on: 
Thursday, February 25, 2021

Results provide further preclinical proof-of-concept for PureTechs Glyph platform technology, which is designed to traffic small molecule therapeutics directly into the lymphatic system via oral administration.

Key Points: 
  • Results provide further preclinical proof-of-concept for PureTechs Glyph platform technology, which is designed to traffic small molecule therapeutics directly into the lymphatic system via oral administration.
  • View the full release here: https://www.businesswire.com/news/home/20210225005700/en/
    PureTech announced the publication of a paper in the Journal of Controlled Release.
  • Results provide further preclinical proof-of-concept for PureTechs lymphatic targeting technology platform Glyph, which is designed to traffic small molecule therapeutics directly into the lymphatic system via oral administration.
  • This in vivo proof of concept is an excellent foundation for advancing drug development that leverages the Glyph platform.

Technological Breakthroughs and Rising Cases of Dental Problems to Boost Growth of the Global Endodontic Consumables Market: TMR

Retrieved on: 
Wednesday, February 24, 2021

Companies in the global endodontic consumables market are seeking ways to transform the treatment procedure of root canals.

Key Points: 
  • Companies in the global endodontic consumables market are seeking ways to transform the treatment procedure of root canals.
  • In a bid to enhance their reputation in the global endodontic consumables market, companies are entering into collaborations with trained experts and industry.
  • The global endodontic consumables market is anticipated to clock a growth rate of ~5%CAGR over the assessment tenure, from 2019 to 2027.
  • Rise in the incidences of dental problems across the globe has stimulated the demand for improved endodontic consumables.